346 related articles for article (PubMed ID: 31258093)
1. The Effect of Low Dose Oral Vitamin D on Bone Mineral Density Changes in HIV Patients: 36 Months Follow Up.
Dhother J; Bopitiya S; Taha H; Das S
Infect Disord Drug Targets; 2020; 20(5):651-658. PubMed ID: 31258093
[TBL] [Abstract][Full Text] [Related]
2. Effect of Low Dose Oral Vitamin-D and Calcium Replacement in HIV Patients.
Das S; Bopitya S; Chowdhury AR; Das A; Taha H
Recent Pat Antiinfect Drug Discov; 2016; 11(1):59-67. PubMed ID: 26844688
[TBL] [Abstract][Full Text] [Related]
3. Relationship between vitamin D, parathyroid hormone, bone mineral density, fracture and antiretroviral therapy in HIV patients.
Das S; Bopitya S; Taha H; David L
Recent Pat Antiinfect Drug Discov; 2014; 9(1):6-13. PubMed ID: 24909536
[TBL] [Abstract][Full Text] [Related]
4. Bone Mineral Density and Vitamin D Levels in HIV Treatment-Naïve African American Individuals Randomized to Receive HIV Drug Regimens.
Cook PP; Stang AT; Walker LR; Akula SM; Cook FJ
South Med J; 2016 Nov; 109(11):712-717. PubMed ID: 27812717
[TBL] [Abstract][Full Text] [Related]
5. Bone mass preservation with high-dose cholecalciferol and dietary calcium in HIV patients following antiretroviral therapy. Is it possible?
Mela Q; Ruggiero V; Montaldo L; Pisano U; Matta L; Maria Pasetto C; Onali S; Cacace E; Carta MG; Barca L; Chessa L
HIV Clin Trials; 2018 Oct; 19(5):188-196. PubMed ID: 30445888
[TBL] [Abstract][Full Text] [Related]
6. Tenofovir disoproxil fumarate appears to disrupt the relationship of vitamin D and parathyroid hormone.
Havens PL; Long D; Schuster GU; Gordon CM; Price G; Wilson CM; Kapogiannis BG; Mulligan K; Stephensen CB;
Antivir Ther; 2018; 23(7):623-628. PubMed ID: 30260797
[TBL] [Abstract][Full Text] [Related]
7. Associations between vitamin D metabolites, antiretroviral therapy and bone mineral density in people with HIV.
Klassen KM; Kimlin MG; Fairley CK; Emery S; Anderson PH; Ebeling PR;
Osteoporos Int; 2016 May; 27(5):1737-45. PubMed ID: 26659069
[TBL] [Abstract][Full Text] [Related]
8. Short communication: Inadequate vitamin D exacerbates parathyroid hormone elevations in tenofovir users.
Childs KE; Fishman SL; Constable C; Gutierrez JA; Wyatt CM; Dieterich DT; Mullen MP; Branch AD
AIDS Res Hum Retroviruses; 2010 Aug; 26(8):855-9. PubMed ID: 20672993
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D status and parathyroid hormone levels in relation to bone mineral density in apparently healthy Syrian adults.
Sayed-Hassan R; Abazid N; Koudsi A; Alourfi Z
Arch Osteoporos; 2016; 11():18. PubMed ID: 27126333
[TBL] [Abstract][Full Text] [Related]
10. Effect of high parathyroid hormone level on bone mineral density in a vitamin D-sufficient population: Korea National Health and Nutrition Examination Survey 2008-2010.
Kim SH; Kim TH; Kim SK
Endocr J; 2014; 61(12):1197-204. PubMed ID: 25242259
[TBL] [Abstract][Full Text] [Related]
11. Effects of vitamin D and calcium supplementation on bone mineral density among Thai youth using daily HIV pre-exposure prophylaxis.
Pornpaisalsakul K; Songtaweesin WN; Tepmongkol S; Wongharn P; Kawichai S; Suponsilchai V; Anugulruengkitt S; Puthanakit T;
J Int AIDS Soc; 2020 Oct; 23(10):e25624. PubMed ID: 33040465
[TBL] [Abstract][Full Text] [Related]
12. Effect of a single 'megadose' intramuscular vitamin D (600,000 IU) injection on vitamin D concentrations and bone mineral density following biliopancreatic diversion surgery.
Einarsdóttir K; Preen DB; Clay TD; Kiely L; Holman CD; Cohen LD
Obes Surg; 2010 Jun; 20(6):732-7. PubMed ID: 19949888
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Impact of Calcium and Vitamin D Supplementation on Bone Density in HIV
Faber J; Bech A; van Bentum P; Gisolf J; Hassing RJ; de Boer H
AIDS Res Hum Retroviruses; 2020 Jan; 36(1):58-64. PubMed ID: 31523978
[TBL] [Abstract][Full Text] [Related]
14. Screening for Vitamin D Deficiency in Black Americans: Comparison of Total, Free, Bioavailable 25 Hydroxy Vitamin D Levels with Parathyroid Hormone Levels and Bone Mineral Density.
McKee A; Lima Ribeiro SM; Malmstrom TK; Perry HM; Miller DK; Farr SS; Niehoff ML; Albert SG
J Nutr Health Aging; 2018; 22(9):1045-1050. PubMed ID: 30379301
[TBL] [Abstract][Full Text] [Related]
15. Impact of switching from zidovudine to tenofovir disoproxil fumarate on bone mineral density and markers of bone metabolism in virologically suppressed HIV-1 infected patients; a substudy of the PREPARE study.
Cotter AG; Vrouenraets SM; Brady JJ; Wit FW; Fux CA; Furrer H; Brinkman K; Sabin CA; Reiss P; Mallon PW;
J Clin Endocrinol Metab; 2013 Apr; 98(4):1659-66. PubMed ID: 23436922
[TBL] [Abstract][Full Text] [Related]
16. Change in vitamin D levels and risk of severe vitamin D deficiency over 48 weeks among HIV-1-infected, treatment-naive adults receiving rilpivirine or efavirenz in a Phase III trial (ECHO).
Wohl DA; Orkin C; Doroana M; Pilotto JH; Sungkanuparph S; Yeni P; Vanveggel S; Deckx H; Boven K
Antivir Ther; 2014; 19(2):191-200. PubMed ID: 24430534
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D, parathyroid hormone levels and bone mineral density in community-dwelling older women: the Rancho Bernardo Study.
von Mühlen DG; Greendale GA; Garland CF; Wan L; Barrett-Connor E
Osteoporos Int; 2005 Dec; 16(12):1721-6. PubMed ID: 15928802
[TBL] [Abstract][Full Text] [Related]
18. Associations of Low Vitamin D and Elevated Parathyroid Hormone Concentrations With Bone Mineral Density in Perinatally HIV-Infected Children.
Jacobson DL; Stephensen CB; Miller TL; Patel K; Chen JS; Van Dyke RB; Mirza A; Schuster GU; Hazra R; Ellis A; Brummel SS; Geffner ME; Silio M; Spector SA; DiMeglio LA;
J Acquir Immune Defic Syndr; 2017 Sep; 76(1):33-42. PubMed ID: 28797019
[TBL] [Abstract][Full Text] [Related]
19. The effect of tenofovir on vitamin D metabolism in HIV-infected adults is dependent on sex and ethnicity.
Klassen K; Martineau AR; Wilkinson RJ; Cooke G; Courtney AP; Hickson M
PLoS One; 2012; 7(9):e44845. PubMed ID: 22984574
[TBL] [Abstract][Full Text] [Related]
20. THE ASSOCIATIONS BETWEEN HYPOVITAMINOSIS D, HIGHER PTH LEVELS WITH BONE MINERAL DENSITIES, AND RISK OF THE 10-YEAR PROBABILITY OF MAJOR OSTEOPOROTIC FRACTURES IN CHINESE PATIENTS WITH T2DM.
Wang XF; Yu JJ; Wang XJ; Jing YX; Sun LH; Tao B; Wang WQ; Ning G; Liu JM; Zhao HY
Endocr Pract; 2018 Apr; 24(4):334-341. PubMed ID: 29658832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
